Picard Medical, Inc.
No enriched coverage for $PMI in the last 7 days.
No SEC Form 4 filings for $PMI in the last 30 days.
Philip Morris International reported Q2 2026 net revenues of $11.2bn, up 10.4% year on year and 7.6% organically. Gross profit rose to $7.7bn and operating income to $4.5bn. Smoke-free shipments increased 7.5%, with IQOS holding a 21.5% Global Travel Retail airport offtake share (Mar-May). PMI plans $1.4bn-$1.6bn capex for 2026.
Perseverance Metals Inc. (TSXV: PMI) says its summer 2026 drill program has started at the Lac Gayot Ni-Cu-Co-PGE project in Québec, focusing on the Venus East Trend. The company plans at least 5,000 metres of drilling plus follow-up of EM anomalies and new surface zones. It also reports Voyageur drilling is delayed but rig testing should begin this week, and granted 75,000 options at $0.65.
Picard Medical, Inc. (PMI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. pmi20260720_8k.htm false 0002030617 0002030617 2026-07-17 2026-07-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event repor
Recent PMI coverage spans corporate actions, market movers and technology.
Results and smoke-free momentum, plus a quantified IQOS share gain in Global Travel Retail, support a constructive near-term read-through for PMI’s growth trajectory.
Commencement of a planned 5,000+ meter drill program increases near-term catalyst visibility for Lac Gayot exploration results.
The approved reverse split authorization and Class B voting redesign can affect share count, liquidity, and governance, potentially influencing near-term trading and risk perception.
The article reinforces progress toward a fully implantable total artificial heart, but it is commentary around previously announced preclinical milestones rather than a new clinical or regulatory datapoint.
Board/committee appointment is a governance update; it may modestly affect perceived oversight quality but is unlikely to change near-term fundamentals.
alphai scores every news story that mentions PMI with an AI model for sentiment and relevance, and aggregates insider trades from Picard Medical, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Philip Morris International reported Q2 2026 net revenues of $11.2bn, up 10.4% year on year and 7.6% organically. Gross profit rose to $7.7bn and operating income to $4.5bn. Smoke-free shipments increased 7.5%, with IQOS holding a 21.5% Global Travel Retail airport offtake share (Mar-May). PMI plans $1.4bn-$1.6bn capex for 2026.
6 min readPerseverance Metals Inc. (TSXV: PMI) says its summer 2026 drill program has started at the Lac Gayot Ni-Cu-Co-PGE project in Québec, focusing on the Venus East Trend. The company plans at least 5,000 metres of drilling plus follow-up of EM anomalies and new surface zones. It also reports Voyageur drilling is delayed but rig testing should begin this week, and granted 75,000 options at $0.65.
4 min readPicard Medical, Inc. (PMI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. pmi20260720_8k.htm false 0002030617 0002030617 2026-07-17 2026-07-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event repor
2 min readPicard Medical (NYSE American: PMI), parent of SynCardia, said an independent commentary in Artificial Organs reviews its next-generation Emperor total artificial heart platform. The journal piece cites prior announcements that three acute large-animal implant procedures succeeded, with stable full circulatory support and no device-related intraoperative failures. It also notes SynCardia’s STAH is the only commercially available FDA and Health Canada-approved total artificial heart.
3 min readPicard Medical, Inc. (PMI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. pmi20260626_8k.htm false 0002030617 0002030617 2026-06-23 2026-06-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event repor
2 min readPicard Medical, Inc. (PMI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. pmi20260618_8k.htm false 0002030617 0002030617 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event repor
2 min readHealthcare stocks rose Tuesday on multiple biotech updates. Bluejay Diagnostics (BJDX) surged 100% after a strategic partnership with Argonaut to advance its Symphony diagnostic platform and announced a private placement up to $23.6M. Picard Medical (PMI) gained 60.33% after completing animal implant studies of its Emperor total artificial heart. Legend Biotech (LEGN) rose 42.22% ahead of EHA Phase 1 data. CUE climbed 18.93% with board changes. Cingulate (CING) rose 11.94% despite the FDA declin
6 min readHealthcare biotech gainers on Tuesday included Bluejay Diagnostics (BJDX), which said it signed a strategic partnership with Argonaut to support its Symphony near-patient diagnostic platform; BJDX shares rose 100% to $4.34 and the company also announced a private placement up to $23.6M. Picard Medical (PMI) reported completed animal implant studies for its next-gen Emperor total artificial heart; shares rose 60.33% to $0.27. Legend Biotech (LEGN) said it will present Phase 1 data for LB2501 show
5 min readPicard Medical (NYSE American: PMI), parent of SynCardia, said it completed an acute in vivo implant study series of its next-generation Emperor Total Artificial Heart at the University of Arizona and Banner University Medical Center. Three procedures showed stable full circulatory support with no device-related intraoperative failures, using an independent dual-motor ventricular design. The Emperor TAH remains under development and is not FDA approved.
4 min readPMI’s short interest fell 57.2% in May, dropping to 475,224 shares as of May 15 from 1,110,773 on April 30, with a short-interest ratio of 0.1 days and about 0.5% of shares sold short. Analysts: HC Wainwright started coverage with a neutral rating; Zacks upgraded to hold. PMI reported May 15 quarterly EPS of -$0.10 on revenue of $1.15M.
5 min read
